Format
Sort by
Items per page

Send to

Choose Destination

Best matches for LEVONORGESTREL/PD:

Kyleena--another hormonal IUD. et al. Med Lett Drugs Ther. (2017)

Levonorgestrel-releasing intrauterine system (LNG-IUS 12) for prevention of pregnancy for up to five years. Nelson AL et al. Expert Rev Clin Pharmacol. (2017)

Liletta--A Third Levonorgestrel-Releasing IUD. et al. Med Lett Drugs Ther. (2015)

Search results

Items: 1 to 20 of 2512

1.

The fate of prazosin and levonorgestrel after electrochemical degradation process: Monitoring by-products using LC-TOF/MS.

Al-Qaim FF, Mussa ZH, Yuzir A, Latip J, Othman MR.

J Environ Sci (China). 2018 Dec;74:134-146. doi: 10.1016/j.jes.2018.02.019. Epub 2018 Mar 7.

PMID:
30340667
2.

Histopathological Evaluation of Combined Impacts of the Synthetic Progestin Levonorgestrel and Temperature on the Female Zebrafish Maturation Using a Semi-quantitative Grading Analysis-Is it Enough?

Cardoso PG, Rodrigues D, Madureira TV, Rocha MJ, Rocha E.

Bull Environ Contam Toxicol. 2018 Oct;101(4):417-422. doi: 10.1007/s00128-018-2436-z. Epub 2018 Sep 5.

PMID:
30187092
3.
4.

Long-acting Reversible Contraception-Highly Efficacious, Safe, and Underutilized.

Wu JP, Moniz MH, Ursu AN.

JAMA. 2018 Jul 24;320(4):397-398. doi: 10.1001/jama.2018.8877. Review. No abstract available.

PMID:
29984374
5.

Comparison of the efficacy of diegnogest and levonorgestrel-releasing intrauterine system after laparoscopic surgery for endometriosis.

Lee KH, Jung YW, Song SY, Kang BH, Yang JB, Ko YB, Lee M, Han HY, Yoo HJ.

J Obstet Gynaecol Res. 2018 Sep;44(9):1779-1786. doi: 10.1111/jog.13703. Epub 2018 Jul 5.

PMID:
29974633
6.

[Efficacy and safety of low-dose levonorgestrel-releasing intrauterine system in Chinese women: a multicenter, single-arm, open labeled interventional trial].

Qian CF, Fan GS, Liao QP, Wu SY, La DD, Di W, Dong BH, Liu HW, Tang LD, Xiong ZA, Zhang HW, Hu YL, Yang NM, Ren ML, Shi H, Deng GP, Huang ZR.

Zhonghua Fu Chan Ke Za Zhi. 2018 Jun 25;53(6):409-413. doi: 10.3760/cma.j.issn.0529-567x.2018.06.009. Chinese.

PMID:
29961284
7.

Randomized, placebo controlled phase I trial of safety, pharmacokinetics, pharmacodynamics and acceptability of tenofovir and tenofovir plus levonorgestrel vaginal rings in women.

Thurman AR, Schwartz JL, Brache V, Clark MR, McCormick T, Chandra N, Marzinke MA, Stanczyk FZ, Dezzutti CS, Hillier SL, Herold BC, Fichorova R, Asin SN, Rollenhagen C, Weiner D, Kiser P, Doncel GF.

PLoS One. 2018 Jun 28;13(6):e0199778. doi: 10.1371/journal.pone.0199778. eCollection 2018.

8.

Women's preferences for the levonorgestrel intrauterine system versus endometrial ablation for heavy menstrual bleeding.

van den Brink MJ, Beelen P, Herman MC, Claassen NJJ, Bongers MY, Geomini PM, van der Steeg JW, van den Wijngaard L, van Wely M.

Eur J Obstet Gynecol Reprod Biol. 2018 Sep;228:143-147. doi: 10.1016/j.ejogrb.2018.06.020. Epub 2018 Jun 12.

PMID:
29945042
9.

Effects of Levonorgestrel and progesterone on Oviductal physiology in mammals.

Li C, Zhang HY, Liang Y, Xia W, Zhu Q, Zhang D, Huang Z, Liang GL, Xue RH, Qi H, He XQ, Yuan JJ, Tan YJ, Huang HF, Zhang J.

Reprod Biol Endocrinol. 2018 Jun 20;16(1):59. doi: 10.1186/s12958-018-0377-3.

10.

Pain Perception during Levonorgestrel-releasing Intrauterine Device Insertion in Nulliparous Women: A Systematic Review.

Anthoulakis C, Iordanidou E, Vatopoulou A.

J Pediatr Adolesc Gynecol. 2018 Dec;31(6):549-556.e4. doi: 10.1016/j.jpag.2018.05.008. Epub 2018 Jun 8.

PMID:
29890206
11.

Low-dose LNG-IUS as Therapy for Endometrial Hyperplasia. A Prospective Cohort Pilot Study.

Sletten ET, Arnes M, Vereide AB, Ørbo A.

Anticancer Res. 2018 May;38(5):2883-2889.

PMID:
29715112
12.

Occurrence of anembryonic pregnancy with use of levonorgestrel subdermal implant (JADELLE®): a case report.

Moutchia-Suh J, Mouemba DM, Ngwasiri CA.

J Med Case Rep. 2018 Apr 29;12(1):111. doi: 10.1186/s13256-018-1675-2.

13.

Levonorgestrel-releasing intra-uterine systems as female contraceptives.

Grandi G, Farulla A, Sileo FG, Facchinetti F.

Expert Opin Pharmacother. 2018 May;19(7):677-686. doi: 10.1080/14656566.2018.1462337. Epub 2018 Apr 11. Review.

PMID:
29637798
14.

Development, validation and utilization of a highly sensitive LC-MS/MS method for quantification of levonorgestrel released from a subdermal implant in human plasma.

Cirrincione LR, Penchala SD, Scarsi KK, Podany AT, Winchester LC, Back DJ, Khoo SH, Fletcher CV, Siccardi M, Else LJ.

J Chromatogr B Analyt Technol Biomed Life Sci. 2018 May 1;1084:106-112. doi: 10.1016/j.jchromb.2018.03.023. Epub 2018 Mar 12.

PMID:
29579732
15.

Bleeding patterns for the Liletta® levonorgestrel 52 mg intrauterine system.

Schreiber CA, Teal SB, Blumenthal PD, Keder LM, Olariu AI, Creinin MD.

Eur J Contracept Reprod Health Care. 2018 Apr;23(2):116-120. doi: 10.1080/13625187.2018.1449825. Epub 2018 Mar 21.

16.

Levonorgestrel-releasing intrauterine system use is associated with a decreased risk of ovarian and endometrial cancer, without increased risk of breast cancer. Results from the NOWAC Study.

Jareid M, Thalabard JC, Aarflot M, Bøvelstad HM, Lund E, Braaten T.

Gynecol Oncol. 2018 Apr;149(1):127-132. doi: 10.1016/j.ygyno.2018.02.006. Epub 2018 Mar 2.

PMID:
29482839
17.

Postinsertional Pain after Intrauterine Device Placement among Nulliparous Adolescents.

Sinning KM, Jude DC, Yoost JL.

J Pediatr Adolesc Gynecol. 2018 Aug;31(4):400-404. doi: 10.1016/j.jpag.2018.02.127. Epub 2018 Feb 17.

PMID:
29462709
18.

Postoperative maintenance levonorgestrel-releasing intrauterine system for symptomatic uterine adenomyoma.

Lin CJ, Hsu TF, Chang YH, Huang BS, Jiang LY, Wang PH, Chen YJ.

Taiwan J Obstet Gynecol. 2018 Feb;57(1):47-51. doi: 10.1016/j.tjog.2017.12.036.

19.

Short- and long-term influence of the levonorgestrel-releasing intrauterine system (Mirena®) on vaginal microbiota and Candida.

Donders GGG, Bellen G, Ruban K, Van Bulck B.

J Med Microbiol. 2018 Mar;67(3):308-313. doi: 10.1099/jmm.0.000657. Epub 2018 Jan 29.

PMID:
29458551
20.

Norethindrone acetate versus extended-cycle oral contraceptive (Seasonique®) in the treatment of endometriosis symptoms: A prospective open-label comparative study.

Scala C, Leone Roberti Maggiore U, Barra F, Venturini PL, Ferrero S.

Eur J Obstet Gynecol Reprod Biol. 2018 Mar;222:89-94. doi: 10.1016/j.ejogrb.2018.01.022. Epub 2018 Feb 3.

PMID:
29408753

Supplemental Content

Loading ...
Support Center